ERF-25104-98624
5 vaccinations
10 coded responses
69 check-ins
9 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 443 / OH
- Registered
- 2021-02-24
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-23
Dose 1 — Moderna
-
2021-02-24
Registered in v-safe
-
2021-02-24
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-02-25
Survey response — days 1–6 daily, dose 1MedDRA: No adverse event — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: NoMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-26
- 2021-02-27
- 2021-02-28
-
2021-03-01
Health check-in — days 1–6 daily, dose 1Feeling: Good · Fatigue or tiredness, Abdominal painAdult check-in
- 2021-03-02
-
2021-03-09
Survey response — day 14, dose 1MedDRA: Injection site rash, Injection site swelling, Injection site warmth — Feeling: GoodFree text: Rash at injection site, raised and hot.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-03-16
- 2021-03-23
-
2021-03-29
Dose 2 — Moderna
- 2021-03-29
-
2021-03-30
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: My fasting blood sugar tosay was 122, 30+ points higher than usual.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Rash, not including the immediate area around the injection site · Be unable to do your normal daily activitiesFree text: My fasting blood surgar today was 30+ highee than usual.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-01
Survey response — days 1–6 daily, dose 2MedDRA: No adverse event — Feeling: Fair · Site: Pain, Redness · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesFree text: No.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Survey response — days 1–6 daily, dose 2MedDRA: Blood glucose increased — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessFree text: Fasting Glucose reading remains 30+ points higher than usual.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-03
Survey response — days 1–6 daily, dose 2MedDRA: Adverse reaction — Feeling: Good · Site: Pain, Redness · Fatigue or tirednessFree text: Fasting glucose levels were closer to normal today, 20+ higher than usual (not 30+)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
- 2021-04-12
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
-
2021-06-28
Survey response — 3 months, dose 2MedDRA: Nasopharyngitis, Sinusitis — Feeling: Good · Be unable to do your normal daily activitiesFree text: Bad cold virus (one week) folowed by a bad sinus infection (second week)MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-09-27
-
2021-10-31
Dose 3 — Moderna
-
2021-10-31
Health check-in — day 0, dose 3Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-11-01
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-02
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-11-04
Survey response — days 1–6 daily, dose 3MedDRA: Injection site rash — Feeling: Good · Site: RednessFree text: Mild rash at injection siteMedDRA releases: 2024-11 · check-in free text available
- 2021-11-05
- 2021-11-06
- 2021-11-07
- 2021-11-14
- 2021-11-21
- 2021-11-28
- 2021-12-05
- 2021-12-12
- 2022-01-30
- 2022-05-01
-
2022-05-05
Dose 4 — Moderna
-
2022-05-05
Health check-in — day 0, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Fatigue or tirednessAdult check-in
-
2022-05-06
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain, Redness · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-05-07
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2022-05-08
Health check-in — days 1–6 daily, dose 4Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
- 2022-05-09
- 2022-05-10
- 2022-05-11
- 2022-05-12
- 2022-05-19
- 2022-05-26
- 2022-06-02
- 2022-06-09
- 2022-06-16
- 2022-08-04
- 2022-11-03
-
2022-11-26
Dose 5 — Pfizer-BioNTech
- 2022-11-26
-
2022-11-27
Health check-in — days 1–6 daily, dose 5Feeling: Fair · Site: Pain · Chills, Headache, Fatigue or tirednessAdult check-in
- 2022-11-28
- 2022-11-29
- 2022-11-30
- 2022-12-01
- 2022-12-02
- 2022-12-03
- 2022-12-10
- 2022-12-17
- 2022-12-24
- 2022-12-31
- 2023-01-07
- 2023-02-27
-
2023-05-27
Survey response — 6 months, dose 5MedDRA: COVID-19 — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-23 | Moderna | |
| 2 | 2021-03-29 | Moderna | |
| 3 | 2021-10-31 | Moderna | No |
| 4 | 2022-05-05 | Moderna | No |
| 5 | 2022-11-26 | Pfizer-BioNTech | No |
Free text
Release 4 — days 1–6 daily, dose 1
Systemic reaction (other): No
Release 5 — day 14, dose 1
Symptoms: Rash at injection site, raised and hot.
Release 6 — days 1–6 daily, dose 2
Systemic reaction (other): My fasting blood sugar tosay was 122, 30+ points higher than usual.
Systemic reaction (other): My fasting blood surgar today was 30+ highee than usual.
Systemic reaction (other): No.
Systemic reaction (other): Fasting Glucose reading remains 30+ points higher than usual.
Systemic reaction (other): Fasting glucose levels were closer to normal today, 20+ higher than usual (not 30+)
Release 9 — 3 months, dose 2
Symptoms: Bad cold virus (one week) folowed by a bad sinus infection (second week)
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Mild rash at injection site
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | COVID-19 | · | · | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Injection site swelling | ✓ | ✓ | ✓ |
| SD | Injection site warmth | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | ✓ | ✓ | ✓ |
| SD | Sinusitis | ✓ | ✓ | ✓ |
| SRO | Adverse reaction | ✓ | ✓ | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Injection site rash | · | · | ✓ |
| SRO | No adverse event | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release